Keyphrases
In Vitro Activation
100%
Tumor Protein p53 (TP53)
100%
HDM2
100%
Cyclotides
100%
HdmX
100%
Tumor Suppressor Activity
100%
Wild-type p53
50%
Tumor Cells
25%
Cancer Cell Lines
25%
Therapeutic Use
25%
Overexpression
25%
Protein-protein Interaction
25%
Therapeutic Strategies
25%
Cell Survival
25%
Human Serum
25%
Potential Therapeutics
25%
Common Mechanisms
25%
Low Bioavailability
25%
High Stability
25%
I to
25%
Intracellular Protein
25%
Poor Stability
25%
Linear Peptide
25%
N-terminal Fragment
25%
P53 Degradation
25%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Suppressor Protein
100%
Protein P53
100%
Cyclotide
100%
Malignant Neoplasm
28%
Therapeutic Use
14%
Cell Protein
14%
Bioavailability
14%
Neoplasm
14%
Immunology and Microbiology
P53
100%
Wild Type
28%
Protein Protein Interaction
14%
Serum (Blood)
14%
Cell Survival
14%
Tumor Cell
14%
Amino Terminal Sequence
14%
Cancer Cell Line
14%